Author: Doctor Evidence

News

Response to the Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset made available to Academic Researchers

Posted on

SANTA MONICA, Calif., March 17, 2020 /PRNewswire/ — Doctor Evidence (“DRE”) is focusing its AI-enabled  medical search engine on the COVID-19 medical literature and daily emerging breaking research. Today, as requested by The White House Office of Science and Technology Policy and in response to researchers call for AI machine-readable technology to address the fast evolving Coronavirus literature, […]

Uncategorized

Efficacy and Safety of Hylan G-F 20 Versus Intra-Articular Corticosteroids

Posted on

AUTHORS: Chevalier X., Sheehan B., Whittington C., Ho C., Ngai W., Campos G. CONFERENCE: 2019 ACR/ARP Annual Meeting DATE: November 8-13, 2019. Objective: To evaluate the clinical efficacy and safety of Hylan G-F 20 in comparison with intra-articular corticosteroids in patients with knee OA, using both direct (pairwise) meta-analysis (MA) and network meta-analysis (NMA). See poster

News

Doctor Evidence is Training AI-Based Technology to Distinguish Real-World Evidence in Literature Search and Monitoring

Posted on

SANTA MONICA, Calif., June 3, 2019 /PRNewswire/ — Doctor Evidence (DRE), a global health technology and healthcare research consulting company, continues to breakthrough artificial intelligence (AI) hurdles with the ability to auto-identify research studies that are based on real-world evidence (RWE). Yesterday, at the AcademyHealth Annual Research Meeting in Washington DC, DRE presented a poster entitled, […]

Uncategorized

Evidence-Based Guidelines: Keeping Current with the Science Between Editions

Posted on

AUTHORS: Sandra Zelman Lewis, PhD, David Feller-Kopman, MD, Craig Whittington, PhD, Melanie Golob, MS, Todd Feinman, MD, and Alex Balekian, MD CONFERENCE: ATS International Conference DATE: May 17-22, 2019 Objective: Objective: To test whether AI search technology could be a useful supplementary search engine to rapidly identify new evidence that matches the inclusion criteria of […]

Poster

OSTEOARTHRITIS, MOBILITY-RELATED COMORBIDITIES AND MORTALITY: AN OVERVIEW OF SYSTEMATIC REVIEWS

Posted on

AUTHORS: Craig Whittington, Ph.D.; Gustavo Campos, M.D.; Raman Mundi, M.D.; Brendan Sheehan, M.D.; Marie-Josée Toutounji, B.Pharm; Yi Xu, MPH.; Wilson Ngai, M.Sc. CONFERENCE: OARSI 2019 DATE: May 2-5, 2019 Objectives Our objective is to examine the relationship between OA and 1) mobility-related comorbidities, specifically diabetes and cardiovascular disease; 2) mortality. See poster 2019-OARSI-DRE-Sanofi-Poster

Poster

HIGH MOLECULAR WEIGHT INTRAARTICULAR HYALURONIC ACID FOR THE TREATMENT OF KNEE OSTEOARTHRITIS: NETWORK META-ANALYSIS

Posted on

AUTHORS: Charles D. Hummer, M.D., Felix Angst M.D., Emil Schemitsch, M.D., Craig Whittington, PhD, Colleen Manitt, PhD, Wilson Ngai CONFERENCE: OARSI 2019 DATE: May 2-5, 2019 See poster 2019-OARSI-DRE-Sanofi-HMW-Poster Purpose: In 2013, the American Academy of Orthopaedic Surgeons (AAOS) clinical practice guideline (CPG) on the treatment of knee osteoarthritis (OA) made a strong recommendation not […]